Restricted accessResearch articleFirst published online 2017-10
The short-term efficacy of vena cava filters for the prevention of pulmonary embolism in patients with venous thromboembolism receiving anticoagulation: Meta-analysis of randomized controlled trials
To perform a meta-analysis of randomized controlled trials assessing the effectiveness of inferior vena cava filters in patients with deep vein thrombosis for preventing pulmonary embolism.
Method
Relevant randomized controlled trials of inferior vena cava filters for the prevention of pulmonary embolism were identified by searching electronic databases updated in February 2016. Relative risks of recurrent pulmonary embolism, recurrent deep vein thrombosis, and mortality at three months were analyzed.
Results
Three published randomized controlled trials were included involving a total of 863 deep vein thrombosis patients. No significant differences were detected with inferior vena cava filters placement with regard to the incidence of recurrent pulmonary embolism or fatal pulmonary embolism. There were also no significant differences in the incidence of recurrent deep vein thrombosis or mortality with inferior vena cava filters placement at three months.
Conclusions
Inferior vena cava filter in addition to anticoagulation was not associated with a reduction in the incidence of recurrent pulmonary embolism as compared with anticoagulation alone in patients with deep vein thrombosis in the short term.
BüllerHRAgnelliGHullRDet al.Antithrombotic therapy for venous thromboembolic disease: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest2004; 126: 401S–428S.
2.
StreiffMB. National Comprehensive Cancer Center N. The National comprehensive cancer center network (NCCN) guidelines on the management of venous thromboembolism in cancer patients. Thromb Res2010; 125(Suppl 2): S128–S133.
3.
MandalaMFalangaARoilaFet al.Management of venous thromboembolism (VTE) in cancer patients: ESMO clinical practice guidelines. Ann Oncol2011; 22(Suppl 6): vi85–vi92.
4.
KonstantinidesSV. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J2014; 35: 3145–3146.
5.
MurielAJimenezDAujeskyDet al.Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk. J Am Coll Cardiol2014; 63: 1675–1683.
6.
AngelLFTapsonVGalgonREet al.Systematic review of the use of retrievable inferior vena cava filters. J Vasc Intervent Radiol2011; 22: 1522–1530 e3.
7.
DebourdeauPFargeDBeckersMet al.International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost2013; 11: 71–80.
8.
YoungTTangHHughesR. Vena caval filters for the prevention of pulmonary embolism. Cochrane Database Syst Rev2010; 2: CD006212–CD006212.
9.
HautERGarciaLJShihabHMet al.The effectiveness of prophylactic inferior vena cava filters in trauma patients: a systematic review and meta-analysis. JAMA Surg2014; 149: 194–202.
10.
DaviesMGHartJPEl-SayedHF. Efficacy of prophylactic inferior vena caval filters in prevention of pulmonary embolism in the absence of deep venous thrombosis. J Vasc Surg Venous Lymphat Disord2016; 4: 127–130 e1.
11.
DecoususHLeizoroviczAParentFet al.A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med1998; 338: 409–415.
12.
MismettiPLaporteSPellerinOet al.Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. JAMA2015; 313: 1627–1635.
13.
GirardPSternJBParentF. Medical literature and vena cava filters: so far so weak. Chest2002; 122: 963–967.
14.
MoherDLiberatiATetzlaffJet al.Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg2010; 8: 336–341.
15.
GroupPS. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation2005; 112: 416–422.
16.
MismettiP. Randomized trial assessing the efficacy of the partial interruption of the inferior vena cava by an optional vena caval filter in the prevention of the recurrence of pulmonary embolism. PREPIC 2 trial: prevention of embolic recurrences by caval interruption (prospective, multicentric, randomised, open trial). Rev Pneumol Clin2008; 64: 328–331.
17.
UsohFHingoraniAAscherEet al.Prospective randomized study comparing the clinical outcomes between inferior vena cava Greenfield and TrapEase filters. J Vasc Surg2010; 52: 394–399.
18.
RajasekharALottenbergLLottenbergRet al.A pilot study on the randomization of inferior vena cava filter placement for venous thromboembolism prophylaxis in high-risk trauma patients. J Trauma2011; 71: 323–328. discussion 8–9.
19.
BarginearMFGrallaRJBradleyTPet al.Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial. Support Care Cancer2012; 20: 2865–2872.
20.
KearonCAklEAOrnelasJet al.Antithrombotic Therapy for VTE disease: CHEST guideline and expert panel report. Chest2016; 149: 315–352.
21.
RajasekharA. Inferior vena cava filters: current best practices. J Thromb Thrombolysis2015; 39: 315–327.
22.
MismettiPRivron-GuillotKQuenetSet al.A prospective long-term study of 220 patients with a retrievable vena cava filter for secondary prevention of venous thromboembolism. Chest2007; 131: 223–229.
23.
CarrierMLe GalGWellsPSet al.Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med2010; 152: 578–589.
24.
AthanasoulisCAKaufmanJAHalpernEFet al.Inferior vena caval filters: review of a 26-year single-center clinical experience. Radiology2000; 216: 54–66.
25.
HeneghanCWardAPereraRet al.Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet2012; 379: 322–334.
26.
GirardPMeyerGParentFet al.Medical literature, vena cava filters and evidence of efficacy. A descriptive review. Thromb Haemost2014; 111: 761–769.
